VAERS Explorer
Back to explore

Report #2877439

Received Dec 11, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
52 yrs
State
PA
Recovered
Unknown
Vaccinated
Dec 8, 2025
Onset
Dec 8, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
YFYELLOW FEVER (YF-VAX)SANOFI PASTEURUNKUK125AAOT / LA

Symptoms (2)

Expired product administeredNo adverse event

Symptom narrative

administration of an expired product with no reported adverse event; Initial information received on 08-Dec-2025 regarding an unsolicited valid non-serious case received from a nurse. This case involves a 52 years old male patient who had administration of an expired YELLOW FEVER VACCINE - US [YF-VAX] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 08-Dec-2025, the patient received an expired 0.5 ml dose of suspect YELLOW FEVER VACCINE - Solution for injection (lot UK125AA, expiry: 31-Oct-2025, Strength: Standard) via subcutaneous route in the left arm as immunization with no reported adverse event (expired product administered) (Latency: same day). It was reported, "Reporter is asking if they expiration date has been extended, or if they should revaccinate. No Treatment, patient is still at the facility. No other immunizations with suspect." Action taken: not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.